E Fund Management Co., Ltd.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1842296
GUANGZHOU, F4
Position in VRTX
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$4,829,776
+$543,391 QoQ
Shares Held
10,816
+12.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026E Fund Management Co., Ltd. holds $77,672,385 across 116 Biotechnology names. VRTX ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
311,825 | $5,912,202 | |
| 2 | EVMN |
Evommune, Inc.
|
243,700 | $5,602,663 | |
| 3 | CELC |
Celcuity Inc.
|
46,337 | $5,288,905 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
10,816 | $4,829,776 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,825 | $3,727,988 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
46,688 | $3,505,801 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
26,231 | $2,184,779 | |
| 8 | AVBP |
ArriVent BioPharma, Inc.
|
93,953 | $2,167,495 |
All Filings in VRTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,829,776 | 10,816 | Shares | Defined | 2026-04-13 | |
| 2025-06-30 | $4,286,385 | 9,628 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,791,960 | 9,884 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,591,777 | 6,436 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $2,513,757 | 5,405 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,479,528 | 5,290 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,767,764 | 4,229 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,770,378 | 4,351 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,540,140 | 4,429 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,404,472 | 3,991 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,402,061 | 4,450 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,337,051 | 4,630 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,372,561 | 11,648 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,424,730 | 5,056 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,178,801 | 4,517 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $970,192 | 4,418 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $831,854 | 4,586 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $895,016 | 4,165 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||